ãã£ãªããã¹ ã¨ã¬ã¯ãããã¯ã¹ ã¸ã£ãã³(ãã£ãªããã¹)ã¯4æ27æ¥ãæ°åãã¬ãã¢ã è¶ é³æ³¢è¨ºæè£ ç½®ãEPIQ Evolution 1.0ãã®è²©å£²ãéå§ããã å社ã®è¶ é³æ³¢è¨ºæè£ ç½®ã®ãã©ãã°ã·ããæ©ã§ãããEPIQããå¤§å¹ ã«ã¢ãã«ãã§ã³ã¸ããåè£ ç½®ã®ç¹å¾´ã¯ãæç´èªè¨¼ã¨åæ§ã®ã¢ã«ã´ãªãºã ãæ¡ç¨ãããAuto Registrationãæ©è½ãæè¼ããç¹ã§ããã ãAuto Registrationãã¯è¶ é³æ³¢è¨ºæè£ ç½®ã¨CTãMRIãªã©ã®ç»åãèªåã§éãåããã¦ãªã¢ã«ã¿ã¤ã ãã¤é«ç²¾åº¦ã«è¡¨ç¤ºããæè¡ãå¾æ¥ã®æ¹æ³ã§ã¯ãç¹ããããã¯ãé¢ãã§ä½ç½®åããããã¦ããããã£ã¡ãã¨éãã¦è¡¨ç¤ºãããã¨ã¯ããã¾ã§å°é£ã¨ãããä½åº¦ã調æ´ãããªããã°ãªããªããªã©ãæéã¨ç²¾åº¦ã®é¢ã§èª²é¡ããã£ãã ããã«å¯¾ãããAuto Registrationãæ©è½ã¯ãé¡èªè¨¼ããã³æç´èªè¨¼ã¨åæ§ã®æè¡ãå°å ¥ãããã¨ã§ããã®èª²é¡ãå æããã3
ææ¥æ°è社ã®ãã¥ã¼ã¹ãµã¤ããææ¥æ°èãã¸ã¿ã«ã®å»çãµã¤ããææ¥æ°èã¢ãã¿ã«ãï¼å»çã»å¥åº·ã»ä»è·ï¼ã«ã¤ãã¦ã®ãã¼ã¸ã§ããææ°è¨äºã®è¦åºãã¯ãã¢ã¤ã³å 社é·ãç¡ç½ªä¸»å¼µãç é¢å è¬å±ã®å ¥æ妨害äºä»¶ãä¸å¯©ã¯æ罪å¤æ±ºãããã¤ãä¿éºè¨¼ãç»é²è§£é¤ã®ç³è«792件ã«ãæ¥æ2æ¥ãã移è¡ãããªã¹ã¯ã¨ã©ãåãåãã°ããã§ããï¼ãå¿çå¦è ãèãã対å¿æ¹æ³ã¨ã¯ããä¸äººæ®ããé«é½¢è ä¸å¸¯ãå¢å ã2050å¹´ã¯32éåºçã§20ï¼ è¶ ã«ãã§ãã
æ¨å¹´ï¼ï¼æããå ¬åãã¦ããã¾ãããããããã«ã¸ã¼ã³ã¨ããï¼ãã®ã¡ã®ã¨ã³ã¸ãã¢ã®ã¯ãªããã«ã¤ã㦠ç·æ°ï¼ï¼ä»¶ã®ãå¿åãããã¾ããã æåªç§è³ä½åã«å¯¾ãã¦ã¯ã第ï¼ï¼åæ¥æ¬è¨åºå·¥å¦ä¼ 5æ23æ¥ï¼åï¼åå¾ããå¸æ°å ¬éè¬åº§ã®çµäºå¾ã« 表彰ãäºå®ãã¦ãã¾ãã ã¾ããåªç§è³ã«ã¯è¡¨å½°ç¶ãå¯è³ãå½ä¼ããå¾æ¥çºéã®äºå®ããã¦ããã¾ãã ãå¿åããã ãã¾ããçæ§ã«ã¯ãååããã ããèª ã«ãããã¨ããããã¾ããã çµæå ±å
é¢é£è¨äº æ±èããã¤ãã³ãåªä½ã微細å å·¥æè¡ã®ãããã¤ã³ããªã³ãã æ°ånmåä½ã®å¾®ç´°å å·¥ã«é©ããæè¡ãããã¤ã³ããªã³ããããã種ã®å°å·æè¡ã使ã£ã¦æ¨¹è表é¢ãªã©ã«å¾®ç´°ãªãã¿ã¼ã³ã転åããç±³å½ã®å¤§å¦çºã®å é²æè¡ã ãåæè¡ã®ç¹è¨±åºé¡ç¶æ³ã調æ»ããããã³ãã»ãªã¶ã«ãã«ããã°ãå¼·ãç¹è¨±ãæã¤ä¸ä½5社ã®ä¸ã«ãæ¥æ¬ä¼æ¥ã¨ãã¦æ±èããã¤ãã³ãå¯å£«ãã¤ã«ã ãå ¥ã£ãã ãã¤ãã³ãçãâç£æ¥ã®ç®âãã«ã¡ã©ãäºåæ©ã§å¹ã£ãæè¡åã製é ã©ã¤ã³ã¸ ãã¤ãã³ã¯2014å¹´4æã«åå ¥ãã3Dãã·ã³ãã¸ã§ã³ã·ã¹ãã ã®ååã«ã¤ãã¦è¨è 説æä¼ãéå¬ããã2017å¹´ã¾ã§ã«å¹´é300å°ã®è²©å£²å°æ°ãç®æãã ãã¤ãã³ããããã¯ã¼ã¯ã«ã¡ã©ä¸çæ大æãè²·åââç£è¦ã«ã¡ã©äºæ¥ãæ¡å¤§ã¸ ãã¤ãã³ã¯ããããã¯ã¼ã¯ã«ã¡ã©ã§ä¸çæ大æã¨ãªãã¹ã¦ã§ã¼ãã³ã®ã¢ã¯ã·ã¹ãè²·åããæ¹éãåºãããç´3337ååã®è²·åè³éã«ãããçºè¡æ¸ã¿ã®å ¨æ ªå¼ã対象ã¨ããå ¬
æ±äº¬å¤§å¦ã大éªå¤§å¦ãæ±å大å¦ã®3大å¦ã¯ç±³ã¹ã¿ã³ãã©ã¼ã大å¦ï¼ã«ãªãã©ã«ãã¢å·ï¼ã¨ææºããä»ç§ããå»çæ©å¨ã®éçºã«ç§ã§ã人æãè²ã¦ãåãçµã¿ãå§ããã大å¦ãä¼æ¥ããå»å¦ãå·¥å¦ãçµå¶ãªã©ç°åéã®å°éç¥èãæã¤ã¡ã³ãã¼ãéããæ°ããªå»çæ©å¨ã試ä½ããã欧米ã«æ¯ã¹ã¦åºé ãã¦ããå»çæ©å¨ã®éçºè¦å¡ãè²æããé¢é£ç£æ¥ã®ç«¶äºåãé«ããèãã ãç±³ã¹ã¿ã³ãã©ã¼ã大ããããã¤ãªãã¶ã¤ã³ãã¨å¼ã°ããå®è·µæè²ããã°ã©
ç·åçã¯ãå½æ°ãå®å¿ãã¦å®å ¨ã«é»æ³¢ãå©ç¨ã§ãã社ä¼ãæ§ç¯ãããã¨ãç®çã¨ãã¦ãçä½é»ç£ç°å¢ã«é¢ããæ¤è¨ä¼ï¼åº§é·ï¼å¤§ä¹ ä¿ãå代次 ä¸è¬è²¡å£æ³äººé»æ°å®å ¨ç°å¢ç 究æé»ç£çæ å ±ã»ã³ã¿ã¼æé·ï¼ãéå¬ãã¦ãã¾ããä»è¬ãåæ¤è¨ä¼ã«ããã¦ç¬¬ä¸æ¬¡å ±åæ¸ï¼æ¡ï¼ãåãã¾ã¨ãããã¾ããã®ã§ãå¹³æ27å¹´4æ30æ¥ï¼æ¨ï¼ããå¹³æ27å¹´6æ3æ¥ï¼æ°´ï¼ã¾ã§ã®éãæè¦ãåéãã¾ãã ç·åçã¯ãé»æ³¢ã®äººä½ãå»çæ©å¨ã¸ã®å®å ¨æ§ã«é¢ããå¹³æ20年度ããçä½é»ç£ç°å¢ã«é¢ããæ¤è¨ä¼ï¼ä»¥ä¸ãæ¬æ¤è¨ä¼ãã¨ããã¾ããï¼ãå®æçã«éå¬ãã¦ãã¾ãããæ¬æ¤è¨ä¼ã¯ãé»æ³¢ã«ãã人ä½ãæ¤è¾¼ã¿åå»çæ©å¨ã¸ã®å½±é¿ã®é²æ¢ã«é¢ããæ¤è¨ãè¡ããã¨ã§ãå½æ°ãå®å¿ãã¦å®å ¨ã«é»æ³¢ãå©ç¨ã§ãã社ä¼ã®æ§ç¯ã«å¯ä¸ãã¦ããã¨ããã§ãã ä»è¬ãæ¬æ¤è¨ä¼ã«ããã¦ãæ¬æ¤è¨ä¼ã®å身ã®ãçä½é»ç£ç°å¢ç 究æ¨é²å§å¡ä¼ï¼å§å¡é·ï¼ä¸éãç §åãä¹å·å¤§å¦å¤§å¦é¢å·¥å¦ç 究é¢ç¹ä»»ææï¼å ±åæ¸å ¬è¡¨å½æï¼
ç±³ãã¥ã¼ã¨ã¼ã¯ã§éããã3Då°å·æè¡ã®ä¼è°ããã³å±è¦§ä¼ã§ãç©ãå°å·ãã3Då°å·æ©ï¼2013å¹´4æ22æ¥æ®å½±ï¼ã(c)AFP/Emmanuel Dunand ã4æ30æ¥ AFPã3Då°å·æè¡ã§ä½æãã移æ¤ç¨çµç¹ãç¨ãã¦ãè´å½çãªæ°éç¾æ£ãæ±ããåã©ã3人ã®å½ãæã£ãã¨ã®ç ç©¶å ±åããç±³å½ã®å»å¸«ãã¼ã ãçºè¡¨ãããå人ã®ç¹å¾´ã«åããã¦ä½æãããè¡å¾ã«ä½ã«å¸åããããã®ç§»æ¤ç¨çµç¹ã¯ã3Dããªã³ã¿ã¼ã®å»å¦çæ´»ç¨ã«æ°ããªåé²ã示ããã®ã ã¨ããã 29æ¥ã®ç±³å»å¦èªããµã¤ã¨ã³ã¹ã»ãã©ã³ã¹ã¬ã¼ã·ã§ãã«ã»ã¡ãã£ã·ã³ï¼Science Translational Medicineï¼ãã«æ²è¼ãããè«æã«ããã¨ãæ°ç®¡éå¡ãå¼ãèµ·ããè´å½çç¾æ£ãæ°ç®¡æ°ç®¡æ¯è»åçãã§æ»ã®å±æ©ã«ç´é¢ãã¦ããä¹³å 3人ã¯ãæ°ç®¡ã®ãæ·»ãæ¨ãã¨ãªãçµç¹ã®ç§»æ¤ãåãã¦å復ããæ¯éãªãå¼å¸ã§ããããã«ãªã£ãã¨ããã å人ã®ä½ã«åããã3Då°å·æè¡ãç¨
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}